American Journal of Ophthalmology
Volume 149, Issue 1 , Page 170 , January 2010

Off-Label Use of Drugs and Devices

References 

  1. Rosenfeld PJ, Goodman KW. When is off-label drug use in the patient's best interest?. [editorial] Am J Ophthalmol. 2009;147:761–763
  2. Theodossiadis PG, Liarakos VS, Sfikakis PP, Vergados IA, Theodossiadis GP. Intravitreal administration of the anti-tumor necrosis factor agent infliximab for neovascular age-related macular degeneration. Am J Ophthalmol. 2009;147:825–830

PII: S0002-9394(09)00660-6

doi: 10.1016/j.ajo.2009.08.034

American Journal of Ophthalmology
Volume 149, Issue 1 , Page 170 , January 2010

Article Tools